This search looks for keywords in all of the website’s content. Search tips
Filter by
HumanVeterinaryCompliance and inspectionsRegulatory and procedural guidanceResearch and development
HumanCompliance and inspectionsRegulatory and procedural guidanceResearch and development
HumanCompliance and inspectionsRegulatory and procedural guidanceResearch and development
HumanCompliance and inspectionsRegulatory and procedural guidanceResearch and development
HumanVeterinaryCompliance and inspectionsRegulatory and procedural guidanceResearch and development
HumanCompliance and inspectionsRegulatory and procedural guidanceResearch and development
During the 2020-23 COVID-19 public health emergency, the European Medicines Agency (EMA) provided guidance for medicine developers and pharmaceutical companies to help speed up development and approval for COVID-19 medicines and address regulatory challenges arising from the pandemic.
HumanCOVID-19Clinical trialsCompassionate useRegulatory and procedural guidanceMedicine shortagesResearch and developmentScientific advice
HumanCompliance and inspectionsRegulatory and procedural guidanceResearch and development
HumanVeterinaryCompliance and inspectionsRegulatory and procedural guidanceResearch and development
EventHumanMedicine shortagesResearch and development